About VIDA
VIDA is a comprehensive clinical imaging intelligence platform that bridges the gap between complex medical imaging and actionable drug development data. The system leverages advanced artificial intelligence to provide precise quantitative endpoints for clinical trials, primarily focusing on respiratory diseases while expanding into cardiovascular and oncology sectors. By integrating AI-powered digital biomarkers into the clinical workflow, VIDA enables biopharmaceutical sponsors to achieve higher precision in their results, potentially saving significant costs and time during the drug development lifecycle. The platform is designed to manage the end-to-end imaging process, ensuring that data is both high-quality and regulatory-compliant. At its core, the VIDA Intelligence Platform is a cloud-native solution that orchestrates data from a global network of over 1,500 sites. Its primary functionality includes automated site onboarding, scanner certification, and ongoing proactive site support to maintain data integrity. The AI engine processes scans to produce up to 15,000 individual metrics per imaging scan, spanning over 50 specific biomarkers that measure airway, tissue, and vascular remodeling. This high level of quantification allows for a more granular understanding of lung function, such as ventilation and air trapping, which are critical for evaluating the efficacy of new respiratory treatments. The platform is ideally suited for clinical trial sponsors, contract research organizations, and life science researchers who require standardized, objective measurements of disease progression. It is particularly effective for trials involving chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung disease (ILD). Beyond standard trial management, VIDA offers a Digital Biobank service that compiles imaging data, test results, and demographics. This allows researchers to discover early disease phenotypes, reveal patterns among responder cohorts, and even leverage data to simulate control arms or create digital twins, modernizing the approach to clinical trial design. VIDA distinguishes itself from generic medical imaging tools through its deep specialization in thoracic intelligence and its robust regulatory framework. The company's quality system is certified to the ISO 13485:2016 standard and complies with FDA Part 11 requirements, ensuring that all data meets the stringent security and privacy standards required for pharmaceutical R&D. Furthermore, VIDA employs a best-of-breed partnership strategy, integrating specialized AI tools for Xenon MRI and deep learning-based fibrosis scoring. This collaborative approach provides users with a broad spectrum of validated analysis tools within a single, unified workflow, making it a comprehensive choice for respiratory-focused clinical development.
FAQs
What therapeutic areas does VIDA support?
While the foundation is in respiratory diseases like COPD and asthma, the platform also supports cardiovascular and oncology trials. Its AI biomarkers are designed to be adaptable across various modalities and therapeutic areas.
Is the VIDA Intelligence Platform compliant with industry standards?
The platform follows rigorous security protocols and is HIPAA compliant. It also meets ISO 13485:2016 standards and FDA Part 11 requirements, using AES256-bit encryption for data security.
What is a Digital Biobank?
A Digital Biobank is a repository of longitudinal patient information, including imaging and demographics, used for research. It helps identify disease phenotypes and can be used to create digital twins or simulate control arms.
How many metrics can the AI generate from a single scan?
VIDA uses AI to generate up to 15,000 individual metrics from a single scan, covering over 50 different biomarkers. These quantify aspects like airway remodeling, tissue changes, and vascular lung function.
Does VIDA provide support for trial sites?
VIDA provides comprehensive site management that includes training and scanner certification. The platform also offers proactive site support to ensure data quality remains high throughout the clinical trial.
